Amedisys Inc
NASDAQ:AMED

Watchlist Manager
Amedisys Inc Logo
Amedisys Inc
NASDAQ:AMED
Watchlist
Price: 90.64 USD 0.53% Market Closed
Market Cap: 3B USD
Have any thoughts about
Amedisys Inc?
Write Note

Intrinsic Value

The intrinsic value of one AMED stock under the Base Case scenario is 115.66 USD. Compared to the current market price of 90.64 USD, Amedisys Inc is Undervalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AMED Intrinsic Value
115.66 USD
Undervaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Amedisys Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for AMED cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about AMED?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Amedisys Inc

Provide an overview of the primary business activities
of Amedisys Inc.

What unique competitive advantages
does Amedisys Inc hold over its rivals?

What risks and challenges
does Amedisys Inc face in the near future?

Has there been any significant insider trading activity
in Amedisys Inc recently?

Summarize the latest earnings call
of Amedisys Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Amedisys Inc.

Provide P/S
for Amedisys Inc.

Provide P/E
for Amedisys Inc.

Provide P/OCF
for Amedisys Inc.

Provide P/FCFE
for Amedisys Inc.

Provide P/B
for Amedisys Inc.

Provide EV/S
for Amedisys Inc.

Provide EV/GP
for Amedisys Inc.

Provide EV/EBITDA
for Amedisys Inc.

Provide EV/EBIT
for Amedisys Inc.

Provide EV/OCF
for Amedisys Inc.

Provide EV/FCFF
for Amedisys Inc.

Provide EV/IC
for Amedisys Inc.

Show me price targets
for Amedisys Inc made by professional analysts.

What are the Revenue projections
for Amedisys Inc?

How accurate were the past Revenue estimates
for Amedisys Inc?

What are the Net Income projections
for Amedisys Inc?

How accurate were the past Net Income estimates
for Amedisys Inc?

What are the EPS projections
for Amedisys Inc?

How accurate were the past EPS estimates
for Amedisys Inc?

What are the EBIT projections
for Amedisys Inc?

How accurate were the past EBIT estimates
for Amedisys Inc?

Compare the revenue forecasts
for Amedisys Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Amedisys Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Amedisys Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Amedisys Inc compared to its peers.

Compare the P/E ratios
of Amedisys Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Amedisys Inc with its peers.

Analyze the financial leverage
of Amedisys Inc compared to its main competitors.

Show all profitability ratios
for Amedisys Inc.

Provide ROE
for Amedisys Inc.

Provide ROA
for Amedisys Inc.

Provide ROIC
for Amedisys Inc.

Provide ROCE
for Amedisys Inc.

Provide Gross Margin
for Amedisys Inc.

Provide Operating Margin
for Amedisys Inc.

Provide Net Margin
for Amedisys Inc.

Provide FCF Margin
for Amedisys Inc.

Show all solvency ratios
for Amedisys Inc.

Provide D/E Ratio
for Amedisys Inc.

Provide D/A Ratio
for Amedisys Inc.

Provide Interest Coverage Ratio
for Amedisys Inc.

Provide Altman Z-Score Ratio
for Amedisys Inc.

Provide Quick Ratio
for Amedisys Inc.

Provide Current Ratio
for Amedisys Inc.

Provide Cash Ratio
for Amedisys Inc.

What is the historical Revenue growth
over the last 5 years for Amedisys Inc?

What is the historical Net Income growth
over the last 5 years for Amedisys Inc?

What is the current Free Cash Flow
of Amedisys Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Amedisys Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Amedisys Inc

Current Assets 579.9m
Cash & Short-Term Investments 245.5m
Receivables 301.1m
Other Current Assets 33.4m
Non-Current Assets 1.6B
PP&E 127.1m
Intangibles 1.3B
Other Non-Current Assets 87.7m
Current Liabilities 486m
Accounts Payable 32.1m
Accrued Liabilities 310.4m
Other Current Liabilities 143.5m
Non-Current Liabilities 505.3m
Long-Term Debt 344.4m
Other Non-Current Liabilities 160.9m
Efficiency

Earnings Waterfall
Amedisys Inc

Revenue
2.3B USD
Cost of Revenue
-1.3B USD
Gross Profit
1B USD
Operating Expenses
-804.7m USD
Operating Income
208.9m USD
Other Expenses
-126m USD
Net Income
82.9m USD

Free Cash Flow Analysis
Amedisys Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

AMED Profitability Score
Profitability Due Diligence

Amedisys Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Positive 3-Year Average ROE
50/100
Profitability
Score

Amedisys Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

AMED Solvency Score
Solvency Due Diligence

Amedisys Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
58/100
Solvency
Score

Amedisys Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AMED Price Targets Summary
Amedisys Inc

Wall Street analysts forecast AMED stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMED is 99.32 USD with a low forecast of 73.73 USD and a high forecast of 106.05 USD.

Lowest
Price Target
73.73 USD
19% Downside
Average
Price Target
99.32 USD
10% Upside
Highest
Price Target
106.05 USD
17% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for AMED?

Click here to dive deeper.

Dividends

Amedisys Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AMED is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

AMED Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

AMED News

Other Videos

Profile

Amedisys Inc Logo
Amedisys Inc

Country

United States of America

Industry

Health Care

Market Cap

3B USD

Dividend Yield

0%

Description

Amedisys, Inc. engages in the provision of healthcare services. The company is headquartered in Baton Rouge, Louisiana and currently employs 21,000 full-time employees. The firm operates through four segments: Home Health, Hospice, Personal Care and high acuity care. The Home Health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with important personal tasks. The Hospice segment provides palliative care and comfort to terminally ill patients and their families. The Personal Care segment provides patients with assistance with the essential activities of daily living. Its high acuity care segment delivers the essential elements of inpatient hospital and skilled nursing facility (SNF) care to patients in their homes. The firm owns and operates approximately 530 care centers in 38 states.

Contact

LOUISIANA
Baton Rouge
3854 American Way Ste A
+12252922031.0
www.amedisys.com

IPO

1994-08-17

Employees

21 000

Officers

President, CEO & Director
Mr. Richard M. Ashworth
Executive VP, COO, CFO & Principal Financial Officer
Mr. Scott G. Ginn
Chief Compliance Officer
Ms. Denise Bohnert
Chief Strategy Officer
Mr. Nick Muscato
Chief Accounting Officer & Principal Accounting Officer
Ms. Allyson Guidroz
CTO & Senior VP of Business Operations Systems
Mr. Pete Hartley
Show More
Acting Chief Information Officer
Mr. Keith Blanchard
Senior VP, Deputy General Counsel, Corporate Secretary & Interim Chief Legal Officer
Ms. Jennifer Guckert Griffin
VP of Marketing & Communications & Media Relations
Kendra Kimmons
Acting Chief People Officer
Ms. Caitlin Franklin
Show Less

See Also

Discover More
What is the Intrinsic Value of one AMED stock?

The intrinsic value of one AMED stock under the Base Case scenario is 115.66 USD.

Is AMED stock undervalued or overvalued?

Compared to the current market price of 90.64 USD, Amedisys Inc is Undervalued by 22%.

Back to Top